The Food and Drug Administration and varenicline: should Risk Communication Be Improved?

Neil M Davies; Kyla H Thomas

doi:10.1111/add.13592

The Food and Drug Administration and varenicline: should Risk Communication Be Improved?

Neil M Davies
, Kyla H Thomas

Research output: Contribution to journal › Editorial (Academic Journal) › peer-review

16 Citations (Scopus)

301 Downloads (Pure)

Abstract

[no abstract]

Original language	English
Pages (from-to)	555–558
Number of pages	4
Journal	Addiction
Volume	112
Issue number	4
Early online date	18 Oct 2016
DOIs	https://doi.org/10.1111/add.13592
Publication status	Published - Apr 2017

Keywords

Adverse drug reactions
evidence based medicine
hierarchy of evidence
nicotine replacement therapy
regulation
varenicline

Access to Document

10.1111/add.13592

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via Wiley at http://onlinelibrary.wiley.com/doi/10.1111/add.13592/abstract. Please refer to any applicable terms of use of the publisher.
Final published version, 240 KBLicence: CC BY

Handle.net

Persistent link

Can instrumental variable analysis overcome confounding by indication? Validation of physicians' prescribing preferences as instrumental variables
Windmeijer, F. (Principal Investigator)
1/07/15 → 1/01/17
Project: Research

Cite this

@article{538a6d725ce94ea29d7c81e8fcbc692e,

title = "The Food and Drug Administration and varenicline: should Risk Communication Be Improved?",

abstract = "[no abstract]",

keywords = "Adverse drug reactions, evidence based medicine, hierarchy of evidence, nicotine replacement therapy, regulation, varenicline",

author = "Davies, \{Neil M\} and Thomas, \{Kyla H\}",

year = "2017",

month = apr,

doi = "10.1111/add.13592",

language = "English",

volume = "112",

pages = "555–558",

journal = "Addiction",

issn = "0965-2140",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - The Food and Drug Administration and varenicline

T2 - should Risk Communication Be Improved?

AU - Davies, Neil M

AU - Thomas, Kyla H

PY - 2017/4

Y1 - 2017/4

N2 - [no abstract]

AB - [no abstract]

KW - Adverse drug reactions

KW - evidence based medicine

KW - hierarchy of evidence

KW - nicotine replacement therapy

KW - regulation

KW - varenicline

U2 - 10.1111/add.13592

DO - 10.1111/add.13592

M3 - Editorial (Academic Journal)

C2 - 27558015

SN - 0965-2140

VL - 112

SP - 555

EP - 558

JO - Addiction

JF - Addiction

IS - 4

ER -

The Food and Drug Administration and varenicline: should Risk Communication Be Improved?

Abstract

Keywords

Access to Document

Handle.net

Fingerprint

Projects

Can instrumental variable analysis overcome confounding by indication? Validation of physicians' prescribing preferences as instrumental variables

Cite this